Silobreaker.com    Log In
   My Page    Help   
360° SearchNetworkHot SpotsTrends
 
Advanced Search Options >>
Saturday, November 21, 2009 8:44 PM

Published 11/03/2009 by Yahoo! Canada


Schering-Plough Reports Potent Antiviral Activity With Narlaprevir (SCH 900518), an Investigational, Once-Daily Protease Inhibitor for Hepatitis C In

BOSTON, Nov. 2 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) today reported that interim results from an ongoing Phase IIa study of narlaprevir (SCH 900518), its investigational, once-daily protease inhibitor, demonstrated potent antiviral activity in treatment-naive patients with...

Share this 

What others report on the same story

AASLD: Once-Daily HCV Protease Inhibitors Show ...
BOSTON -- Two investigational drugs targeting the hepatitis C virus (HCV) protease enzyme helped patients clear the virus with once-daily dosing, contrasting with ... - [11/03/2009 - MedPage Today]
Schering-Plough Reports Potent Antiviral Activi...
BOSTON 'These interim results, while preliminary, are very encouraging, and showed that narlaprevir has potent antiviral activity in hepatitis C,' said John Vierling, ... - [11/02/2009 - Forbes.com]
Market Report -- In Play (SGP)
Schering-Plough reports potent antiviral activity with Narlaprevir (SCH 900518), an investigational, once-daily protease inhibitor for hepatitis C Co reported that ... - [11/02/2009 - Briefing.com via MSN Money]

Quotes

"These interim results, while preliminary, are very encouraging, and showed that narlaprevir has potent antiviral activity in hepatitis C" said John Vierling...
Schering-Plough Reports Potent Antiviral Activity With Narlaprevir (SCH 900518), an Investigation ... [Yahoo! Canada - 11/03/2009]
...of the study. "In this study, once-daily narlaprevir greatly improved viral clearance at week 4 of treatment in genotype 1 hepatitis C infection compared to the control group. We look forward to further results from this ongoing study."
Schering-Plough Reports Potent Antiviral Activity With Narlaprevir (SCH 900518), an Investigation ... [Yahoo! Canada - 11/03/2009]

Related Stories

First Reported 11/03/2009 - Updated 11/04/2009 - 13 Documents (in Internet & IT)
Merck & Co Inc - Click to view image in its original context
Merck & Co Inc
Merck Set To Complete $41 Billion Acquisition Of Schering-Plough (MRK,SGP,PFE)
11/3/2009 - Merck & Co. (NYSE:MRK) is set to complete the $41 billion acquisition of Schering-Plough Corp. (NYSE:SGP) later Tuesday. The acquisition will create the second-largest drugmaker, behind Pfizer (NYSE:PFE). The deal is expected to close after ... [Individual.com - 11/04/2009]
First Reported 11/03/2009 - Updated 11/04/2009 - 9 Documents (in Corporate Deals)
Animal Health International Inc - Click to view 360-page
Animal Health International Inc
Merck, Schering-Plough complete merger
(11/4/2009) Rod Smith Merck & Co. and Schering-Plough Corp. completed a merger yesterday afternoon after receiving final clearances yesterday morning, according to an announcement.The merger pulls Intervet/Schering Plough Animal Health, the largest animal ... [Feedstuffs - 11/04/2009]
First Reported 11/04/2009 - Updated 11/05/2009 - 7 Documents (in Corporate Deals)
New York Stock Exchange - Click to view 360-page
New York Stock Exchange
Merck's acquisition of Schering-Plough is completed
US pharmaceutical company Merck & Co Inc (NYSE:MRK) confirmed on Tuesday that it has completed its USD41.1bn takeover of smaller rival Schering-Plough Corporation (NYSE:SGP).Schering-Plough shareholders will receive 0.5767 shares of the combined company ... [M2 - 11/05/2009]
First Reported 10/29/2009 - Updated 10/30/2009 - 9 Documents (in Corporate Deals)
Merck & Co., Inc and Schering-Plough Corporation Receive Merger Approvals
The Swiss Competition Commission, U.S. Federal Trade Commission, and Canadian Competition Bureau approve Merck and Schering-Plough merger...Merck. & Co., Inc. (NYSE: MRK) and Schering-Plough Corporation (NYSE: SGP) today announced that they have ... [Healthcare Digital - 10/30/2009]
First Reported 10/30/2009 - Updated 10/31/2009 - 7 Documents (in Corporate Deals)
U.S. Federal Trade Commission Ok's Merck & Co., Inc. (MRK) (JOBS)-Schering-Plough Corporation (SGP) (JOBS) Deal with Conditions
WHITEHOUSE STATION, N.J. & KENILWORTH, N.J.--(BUSINESS WIRE)--Merck & Co., Inc. and Schering-Plough Corporation (NYSE: SGP - News) today announced that they have received clearance from the U.S. Federal Trade Commission (FTC), the Swiss Competition Commission ... [BioSpace - 10/31/2009]
First Reported 10/30/2009 - Updated 10/30/2009 - 3 Documents (in Medicine)
Schering Plough Corporation - Click to view 360-page
Schering Plough Corporation
U.S. Food and Drug Administration Issues Complete Response Letter Regarding PEGINTRON(R) for Malignant Melanoma
emphysema, bronchiolitis obliterans, pleural effusion, gastroenteritis, pancreatitis, gout, hyperglycemia, hyperthyroidism and hypothyroidism, autoimmune thrombocytopenia with or without purpura, rheumatoid arthritis, interstitial nephritis, lupus-like ... [Earthtimes.org - 10/30/2009]
First Reported 10/30/2009 - Updated 10/30/2009 - 2 Documents
Costco Wholesale Corporation - Click to view image in its original context
Costco Wholesale Corporation
Critical Alerts for Cisco, Schering-Plough, BHP Billiton, Costco,
Seven Summits Research issues PriceWatch Alerts for , , , , and . Seven Summits Strategic Investments' PriceWatch Alerts are available at (Note: You may have to copy this link into your browser then press the [ENTER] key.)Today's PriceWatch Alerts cover ... [PR Newswire via MSN Money - 10/30/2009]
First Reported 10/28/2009 - Updated 10/29/2009 - 2 Documents (in Health)
Vertex Pharma Said Hepatitis C Treatment Showed Positive Results In Patients (VRTX)
10/28/2009 - Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) said Wednesday that its hepatitis C treatment telaprevir created an immune system response to the virus in patients who had no response to other drugs. The results came from a midstage trial of the ... [Individual.com - 10/29/2009]
First Reported 11/03/2009 - Updated 11/03/2009 - 1 Documents (in Corporate Deals)
Merck set to close US$41 - billion purchase of Schering - Plough
TRENTON, N.J. - Merck&Co. is set to complete its US$41-billion acquisition of Schering-Plough Corp. later Tuesday, creating the world's second-largest drugmaker, behind Pfizer Inc.The companies expect the deal will close after the end of market trading ... [Canadian Business Magazine - 11/03/2009]
In Focus
Network

Blogs

sort by: Date | Relevance
Thoughts on What Used to Be Schering-Plough [Corante - 11/07/2009]
So what are we up to now, Day Three of Greater Merck? The merger with Schering-Plough went through earlier this week, and you won't get any more numbers by searching ...
Thoughts on What Used to Be Schering-Plough [In the Pipeline - 11/06/2009]
So what are we up to now, Day Three of Greater Merck? The merger with Schering-Plough went through earlier this week, and you won't get any more numbers by searching ...
FTC clears Merck's acquisition of Schering-Plough [The Deal.com - 10/30/2009]
The Federal Trade Commission gave final U.S. approval Thursday to the merger of two pharmaceutical giants -- Merck & Co.'s $41.1 billion takeover of Schering-Plough ...
FTC clears Merck's acquisition of Schering-Plough [Dealscape - 10/30/2009]
The Federal Trade Commission gave final U.S. approval Thursday to the merger of two pharmaceutical giants -- Merck & Co.'s $41.1 billion takeover of Schering-Plough ...
Selling It, And Selling It Hard [Corante - 11/10/2009]
There's a long, detailed article up over at Bloomberg on the recent run of huge fines for off-label promotion of drugs. Pfizer, Lilly, Bristol-Meyers Squibb, and ...
1 2 3 4

  •  
  •  
  •